Tag Archives: NASDAQ:TSPT

Questcor Pharmaceuticals (NASDAQ:QCOR) First Quarter Profit Hikes But Misses Estimates – QCOR, PFE, TSPT, FRX

Posted on May 1, 2013 by Thomas Vedder

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) declared fiscal Q1 profit hiked from previous year, showing strong double-digit sales expansion amid contribution from acquisition of BioVectra, Inc.

Biotechnology Company announced net income was $39.06 million or $0.65 a share for fiscal Q1, over …

Posted in Healthcare, Latest Headlines | Tagged Forest Laboratories, FRX, NASDAQ:QCOR, NASDAQ:TSPT, NYSE:FRX, NYSE:PFE, PFE, Pfizer, QCOR, Questcor Pharmaceuticals, Transcept Pharmaceuticals, TSPT | Comments Off

Alexza Pharmaceuticals (NASDAQ:ALXA) Wins Approval for Adasuve by FDA – ALXA, SOMX, TSPT, XNPT

Posted on December 24, 2012 by Geoff Noir

Alexza Pharmaceuticals, Inc (NASDAQ:ALXA) reported on Saturday that the United States Food and Drug Administration approved its schizophrenia and bipolar disorder treatment Adasuve, one more latest win for the Mountain View, California based small drug manufacturer.

The medicine was approved …

Posted in Healthcare, Latest Headlines | Tagged Alexza Pharmaceuticals, ALXA, NASDAQ:ALXA, NASDAQ:SOMX, NASDAQ:TSPT, NASDAQ:XNPT, Somaxon, SOMX, Transcept, TSPT, XenoPort, XNPT | Comments Off

What the fuss Assured Guaranty, Transcept Pharma and Scorpio Tankers?

Posted on December 1, 2011 by Josie Middleton

In this report: Assured Guaranty Ltd. (NYSE:AGO), Transcept Pharmaceuticals (NASDAQ:TSPT) and Scorpio Tankers Inc. (NYSE:STNG).

Assured Guaranty Ltd. (NYSE:AGO) is trading over 17 percent higher today after rating firm Standard & Poor kept its grades in the same tier and …

Posted in Latest Headlines, Reports | Tagged AA, AGO, Assured Guaranty Ltd., businesses, capital, company, default, FDA, firm, insurance, Intermezzo, marketing, milestone, NASDAQ, NASDAQ:TSPT, NYSE, NYSE:AGO, NYSE:STNG, orange book, payments, public offering, Purdue, rating, report, royalty, sales, Scorpio Tankers Inc., shares, Standard & Poor, STNG, trading, Transcept Pharmaceuticals, TSPT | Comments Off

3 stocks to watch (TSPT, CMCSA, MGM)

Posted on October 4, 2011 by Martin Timble

In this report: Transcept Pharmaceuticals Inc. (NASDAQ:TSPT), MGM Resorts (NYSE:MGM) and Comcast Corp. (NASDAQ:CMCSA).

Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) has soared by more than 27 percent today on revived hopes that its experimental sleep drug could get FDA approval after it …

Posted in Latest Headlines, Reports | Tagged approval, CMSCA, Comcast Corp, company, concerns, credit, drug, FDA, Federal Drug and Food Administration, Focus List, gambling, Intermezzo, JP Morgand, Macau, MGM, MGM Resorts, NASDAQ, NASDAQ:CMCSA, NASDAQ:TSPT, NYSE, NYSE:MGM, revenue, slowdown, stock, Transcept Pharmaceuticals Inc, treatment, TSPT, upgrade | Comments Off

What the Fuss Transcept Pharmaceuticals, Kroger and NCR?

Posted on September 15, 2011 by Josie Middleton

In this report: Transcept Pharmaceuticals Inc. (NASDAQ:TSPT), Kroger Co. (NYSE:KR) and NCR Corp. (NYSE:NCR).

Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) has surged more that 97 percent today and become the largest percentage gainer on the Nasdaq after reporting that it plans to …

Posted in Latest Headlines, Main Post, Reports | Tagged agreed, approval, ATM machine, business, company, coverage, dividend, drug, drug aplication, FDA, firm, Food and Drug Administration, grocery store, initiated, Intermezzo, KR, Kroger, maker, NASDAQ, NASDAQ:TSPT, NCR, NCR Corp., NYSE:KR, NYSE:NCR, operator, Oppenheimer, price target, Radiant Systems, rates, records, repurchase program, shareholders, shares, stock, Transcept Pharmaceuticals, TSPT, yield | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.